Cite
Al Feghali KA, Randall JW, Liu DD, et al. Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment. Neurooncol Adv. 2021;3(1):vdab073doi: 10.1093/noajnl/vdab073.
Al Feghali, K. A., Randall, J. W., Liu, D. D., Wefel, J. S., Brown, P. D., Grosshans, D. R., McAvoy, S. A., Farhat, M. A., Li, J., McGovern, S. L., McAleer, M. F., Ghia, A. J., Paulino, A. C., Sulman, E. P., Penas-Prado, M., Wang, J., de Groot, J., Heimberger, A. B., Armstrong, T. S., Gilbert, M. R., Mahajan, A., Guha-Thakurta, N., & Chung, C. (2021). Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment. Neuro-oncology advances, 3(1), vdab073. https://doi.org/10.1093/noajnl/vdab073
Al Feghali, Karine A, et al. "Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment." Neuro-oncology advances vol. 3,1 (2021): vdab073. doi: https://doi.org/10.1093/noajnl/vdab073
Al Feghali KA, Randall JW, Liu DD, Wefel JS, Brown PD, Grosshans DR, McAvoy SA, Farhat MA, Li J, McGovern SL, McAleer MF, Ghia AJ, Paulino AC, Sulman EP, Penas-Prado M, Wang J, de Groot J, Heimberger AB, Armstrong TS, Gilbert MR, Mahajan A, Guha-Thakurta N, Chung C. Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment. Neurooncol Adv. 2021 Jun 01;3(1):vdab073. doi: 10.1093/noajnl/vdab073. eCollection 2021. PMID: 34337411; PMCID: PMC8320688.
Copy
Download .nbib